Enriched in body wall musculature; intestine; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Doxycycline; Ketamine; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LysM domain superfamily; LysM domain; and LysM and putative peptidoglycan-binding domain-containing protein 1-4. Is an ortholog of human LYSMD1 (LysM domain containing 1) and LYSMD2 (LysM domain containing 2).
Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.